Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
NCT05146999
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
QM1114-DP
BIOLOGICAL:
Placebo
Sponsor
Galderma R&D